Delving into the Latest Updates on Sanofi KK /Kawagoe Pharmaceutical Factory/ with Synapse

Overview

Primary objective: To determine the bioequivalence of clopidogrel and aspirin (ASA) in a combination tablet containing 75 mg clopidogrel and 100 mg enteric-coated ASA (test formulation) with the concomitant administration of a single commercially available tablet (reference formulation) in healthy Chinese subjects in the fed state Secondary objective: To evaluate the clinical safety of the two formulations

Start Date11 Mar 2019

Sponsor / Collaborator

Sanofi Winthrop Industrie SA

[+3]

CTR20181695 / CompletedPhase 1

在健康中国受试者中比较含氯吡格雷和肠溶阿司匹林的复方片剂与同时给予这两种药物单方制剂的生物等效性研究

[Translation] Bioequivalence study comparing a combination tablet containing clopidogrel and enteric-coated aspirin with the simultaneous administration of these two drugs as single-drug formulations in healthy Chinese subjects

主要目的：确定含75 mg 氯吡格雷和100 mg 肠溶ASA 的复方片剂ComPlavin®（受试制剂）中氯吡格雷和阿司匹林（ASA）与同时给予单方市售片剂（参比制剂）在健康中国受试者中的生物等效性次要目的：评价两种制剂的临床安全性

[Translation]

Primary objective: To determine the bioequivalence of clopidogrel and aspirin (ASA) in a combination tablet containing 75 mg clopidogrel and 100 mg enteric-coated ASA (ComPlavin®, test formulation) with a single commercially available tablet (reference formulation) in healthy Chinese subjects Secondary objective: To evaluate the clinical safety of the two formulations

Start Date15 Oct 2018

Sponsor / Collaborator

Sanofi Winthrop Industrie SA

[+3]

100 Clinical Results associated with Sanofi KK /Kawagoe Pharmaceutical Factory/

Login to view more data

0 Patents (Medical) associated with Sanofi KK /Kawagoe Pharmaceutical Factory/

Login to view more data

100 Deals associated with Sanofi KK /Kawagoe Pharmaceutical Factory/

Login to view more data

100 Translational Medicine associated with Sanofi KK /Kawagoe Pharmaceutical Factory/

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data